199 related articles for article (PubMed ID: 31830625)
1. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
2. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
Ouyang J
Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
[TBL] [Abstract][Full Text] [Related]
3. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
Gilroy JJ; Eakin CM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
[TBL] [Abstract][Full Text] [Related]
4. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
5. Design and characterization of homogenous antibody-drug conjugates with a drug-to-antibody ratio of one prepared using an engineered antibody and a dual-maleimide pyrrolobenzodiazepine dimer.
White JB; Fleming R; Masterson L; Ruddle BT; Zhong H; Fazenbaker C; Strout P; Rosenthal K; Reed M; Muniz-Medina V; Howard P; Dixit R; Wu H; Hinrichs MJ; Gao C; Dimasi N
MAbs; 2019 Apr; 11(3):500-515. PubMed ID: 30835621
[TBL] [Abstract][Full Text] [Related]
6. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
[TBL] [Abstract][Full Text] [Related]
7. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
[TBL] [Abstract][Full Text] [Related]
9. ADC Analysis by Hydrophobic Interaction Chromatography.
Fleming R
Methods Mol Biol; 2020; 2078():147-161. PubMed ID: 31643055
[TBL] [Abstract][Full Text] [Related]
10. Impact of drug-linker on method selection for analytical characterization and purification of antibody-drug conjugates.
Santora LC; Hobson AD; Wang L; Wu KX
Anal Methods; 2024 Jun; 16(22):3492-3503. PubMed ID: 38770747
[TBL] [Abstract][Full Text] [Related]
11. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
Yan Y; Xing T; Wang S; Daly TJ; Li N
J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
[TBL] [Abstract][Full Text] [Related]
12. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
[TBL] [Abstract][Full Text] [Related]
13. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future.
Beck A; D'Atri V; Ehkirch A; Fekete S; Hernandez-Alba O; Gahoual R; Leize-Wagner E; François Y; Guillarme D; Cianférani S
Expert Rev Proteomics; 2019 Apr; 16(4):337-362. PubMed ID: 30706723
[TBL] [Abstract][Full Text] [Related]
14. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
[TBL] [Abstract][Full Text] [Related]
15. Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
Källsten M; Pijnappel M; Hartmann R; Lehmann F; Kovac L; Lind SB; Bergquist J
Anal Bioanal Chem; 2019 May; 411(12):2569-2576. PubMed ID: 30848315
[TBL] [Abstract][Full Text] [Related]
16. Native Reversed-Phase Liquid Chromatography: A Technique for LCMS of Intact Antibody-Drug Conjugates.
Chen TH; Yang Y; Zhang Z; Fu C; Zhang Q; Williams JD; Wirth MJ
Anal Chem; 2019 Feb; 91(4):2805-2812. PubMed ID: 30661356
[TBL] [Abstract][Full Text] [Related]
17. Systematic Variation of Pyrrolobenzodiazepine (PBD)-Dimer Payload Physicochemical Properties Impacts Efficacy and Tolerability of the Corresponding Antibody-Drug Conjugates.
Staben LR; Chen J; Cruz-Chuh JD; Del Rosario G; Go MA; Guo J; Khojasteh SC; Kozak KR; Li G; Ng C; Lewis Phillips GD; Pillow TH; Rowntree RK; Wai J; Wei B; Xu K; Xu Z; Yu SF; Zhang D; Dragovich PS
J Med Chem; 2020 Sep; 63(17):9603-9622. PubMed ID: 32787101
[TBL] [Abstract][Full Text] [Related]
18. A rapid on-line method for mass spectrometric confirmation of a cysteine-conjugated antibody-drug-conjugate structure using multidimensional chromatography.
Birdsall RE; Shion H; Kotch FW; Xu A; Porter TJ; Chen W
MAbs; 2015; 7(6):1036-44. PubMed ID: 26305867
[TBL] [Abstract][Full Text] [Related]
19. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 May; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
20. Impact of organic modifier and temperature on protein denaturation in hydrophobic interaction chromatography.
Bobaly B; Beck A; Veuthey JL; Guillarme D; Fekete S
J Pharm Biomed Anal; 2016 Nov; 131():124-132. PubMed ID: 27589029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
